companyNews

U.S. carmakers expected to warn of tariff pain when releasing results

When Detroit’s automakers report earnings on Wednesday, they are likely to highlight escalating tariffs and use the opportunity to warn investors of far greater pain ahead should U.S. President Donald Trump impose broader tariffs on the industry’s vehicles and parts,

/ Kommentarer lukket til U.S. carmakers expected to warn of tariff pain when releasing results

U.S. carmakers expected to warn of tariff pain when releasing results

When Detroit’s automakers report earnings on Wednesday, they are likely to highlight escalating tariffs and use the opportunity to warn investors of far greater pain ahead should U.S. President Donald Trump impose broader tariffs on the industry’s vehicles and parts,

/ Kommentarer lukket til U.S. carmakers expected to warn of tariff pain when releasing results

UPDATE 1-Deutsche to pay $75 mln to settle ADRs abuses case, U.S. SEC says

The U.S. Securities and Exchange Commission said on Friday that Deutsche Bank has agreed to pay nearly $75 million to settle an investigation into the mishandling of pre-release American Depositary Receipts (ADR).

/ Kommentarer lukket til UPDATE 1-Deutsche to pay $75 mln to settle ADRs abuses case, U.S. SEC says

UPDATE 1-Deutsche to pay $75 mln to settle ADRs abuses case, U.S. SEC says

The U.S. Securities and Exchange Commission said on Friday that Deutsche Bank has agreed to pay nearly $75 million to settle an investigation into the mishandling of pre-release American Depositary Receipts (ADR).

/ Kommentarer lukket til UPDATE 1-Deutsche to pay $75 mln to settle ADRs abuses case, U.S. SEC says

UPDATE 1-Agios Pharmaceuticals leukemia drug gets U.S. approval

Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic mutation.

/ Kommentarer lukket til UPDATE 1-Agios Pharmaceuticals leukemia drug gets U.S. approval

UPDATE 1-Agios Pharmaceuticals leukemia drug gets U.S. approval

Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic mutation.

/ Kommentarer lukket til UPDATE 1-Agios Pharmaceuticals leukemia drug gets U.S. approval